George Renaudin II - 21 Feb 2024 Form 4 Insider Report for HUMANA INC (HUM)

Role
President, Medicare & Medicaid
Signature
George Renaudin II
Issuer symbol
HUM
Transactions as of
21 Feb 2024
Net transactions value
-$101,777
Form type
4
Filing time
23 Feb 2024, 11:53:12 UTC
Previous filing
19 Dec 2023
Next filing
01 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUM Humana Common Options Exercise $0 +1,104 +71% $0.000000 2,651 22 Feb 2024 Direct F12
transaction HUM Humana Common Tax liability $101,777 -278 -10% $366.10 2,373 22 Feb 2024 Direct F13
transaction HUM Humana Common Award $0 +7,250 +306% $0.000000 9,623 21 Feb 2024 Direct F9, F10
holding HUM Humana Common 489 21 Feb 2024 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Options Award $0 +6,966 $0.000000 6,966 21 Feb 2024 Humana Common 6,966 $367.21 Direct F3
holding HUM Options 4,162 21 Feb 2024 Humana Common 4,162 $510.24 Direct F2
holding HUM Restricted Stock Units 1,241 21 Feb 2024 Humana Common 1,241 Direct F4, F5
holding HUM Restricted Stock Units 230 21 Feb 2024 Humana Common 230 Direct F4, F6
holding HUM Restricted Stock Units 609 21 Feb 2024 Humana Common 609 Direct F4, F7
holding HUM Restricted Stock Units 719 21 Feb 2024 Humana Common 719 Direct F4, F8
holding HUM Phantom Stock Units 153 21 Feb 2024 Humana Common 153 See Footnote F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held for the benefit of reporting person as of January 31, 2024 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
F2 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F3 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
F4 Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F5 Restricted stock units granted to reporting person on 9/1/2021, 100% of the award is vesting on 9/1/2024.
F6 Restricted stock units granted to reporting person on 2/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F7 Restricted stock units granted to reporting person on 10/1/2022, 100% of the award is vesting on 10/1/2025.
F8 Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F9 Restricted stock units granted to reporting person on 2/21/24.
F10 Includes 7,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
F11 Phantom Stock Units held for the benefit of reporting person as of January 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.
F12 Includes Performance Stock Units not required to be reported until vest.
F13 Shares disposed of represent payment for tax liability on Performance Stock Units vesting on 2/22/24.